首页> 外文会议>Society for Biomaterials annual meeting and exposition >The Combination of BIBF 1120 (BIBF) and Paclitaxel (PTX) Independently Loaded in PLGA Nanoparticles as a Treatment #for Endometrial Cancer (EC)

【24h】

The Combination of BIBF 1120 (BIBF) and Paclitaxel (PTX) Independently Loaded in PLGA Nanoparticles as a Treatment #for Endometrial Cancer (EC)

机译：独立装载于PLGA纳米粒子中的BIBF 1120（BIBF）和紫杉醇（PTX）的组合作为子宫内膜癌（EC）的治疗方法

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Conclusions: The enhanced retardation of tumor growth observed in Hec50co tumor-challenged mice when treated with a combination of PTXp (75/T) and BIBFp (75/T) suggests that this therapy could be a promising new treatment for patients diagnosed with EC.

机译：结论：用PTXp（75 / T）和BIBFp（75 / T）联合治疗时，在Hec50co肿瘤攻击的小鼠中观察到的肿瘤生长增强增强表明，该疗法对于诊断为EC的患者可能是一种有希望的新疗法。

著录项

来源
《Society for Biomaterials annual meeting and exposition》|2017年|419-419|共1页
会议地点
作者
Kareem Ebeid; Xiangbing Meng; Anh-Vu Do; Amaraporn Wongrakpanich; Sean Geary; Kristina Thiel; Kimberly Leslie; Aliasger K Salem;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
专利

1. A phase I, open-label dose-escalation study of continuous treatment with bibf 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer [J] . DoebeleR.C., ConklingP., TraynorA.M., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第8期

机译：I期开放标签剂量递增研究连续进行以bibf 1120联合紫杉醇和卡铂作为晚期非小细胞肺癌患者的一线治疗
2. A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer [J] . R. C. Doebele1* P. Conkling23 A. M. Traynor4 G. A. Otterson5 Y. Zhao6 S. Wind7 P. Stopfer7 R. Kaiser7 and D. R. Camidge1⇓ Annals of Oncology . 2012,第8期

机译：晚期非小细胞肺癌患者以BIBF 1120联合紫杉醇和卡铂作为一线治疗连续治疗的一期开放标签剂量递增研究
3. A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study [J] . Dizon Don S., Sill Michael W., Schilder Jeanne M., Gynecologic Oncology: An International Journal . 2014,第3期

机译：Nintedanib（BIBF-1120）在复发性或持续性子宫内膜癌治疗的II期评估：NRG肿瘤/妇科肿瘤小组研究
4. The Combination of BIBF 1120 (BIBF) and Paclitaxel (PTX) Independently Loaded in PLGA Nanoparticles as a Treatment #for Endometrial Cancer (EC) [C] . Kareem Ebeid, Xiangbing Meng, Anh-Vu Do, Society for Biomaterials annual meeting and exposition . 2017

机译：Bibf 1120（BibF）和紫杉醇（PTX）的组合独立地在PLGA纳米粒子中作为治疗组成＃对子宫内膜癌（EC）
5. Combination of Photodynamic Therapy and Chemotherapy for Cancer Treatment by Using Paclitaxel-Loaded Porphyrin-Shelled Nanoemulsions [D] . Chang, Enling. 2021

机译：用紫杉醇负载卟啉壳纳米乳液使用光动力治疗和化疗对癌症治疗的组合
6. A phase I open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer [O] . R. C. Doebele, P. Conkling, A. M. Traynor, -1

机译：晚期非小细胞肺癌患者以BIBF 1120联合紫杉醇和卡铂作为一线治疗连续治疗的一期开放标签剂量递增研究
7. A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer [O] . R.C. Doebele, P. Conkling, A.M. Traynor, 2012

机译：I期，开放标签剂量升级研究与BIBF 1120结合紫杉醇和卡铂作为先进的非小细胞肺癌患者的一线治疗
8. Targeting Paclitaxel-Loaded Nanoparticles to Ovarian Cancer. [R] . Howell, S. B. 2013

机译：将紫杉醇负载的纳米粒子靶向卵巢癌。

The Combination of BIBF 1120 (BIBF) and Paclitaxel (PTX) Independently Loaded in PLGA Nanoparticles as a Treatment #for Endometrial Cancer (EC)

摘要

著录项

相似文献

相关主题

期刊订阅